• Return to Headlines

Highest Price to Last Quarter Annualized Sales Ratio in the Pharmaceuticals Industry Detected in Shares of Otonomy Inc (OTIC, LPCN, COLL, ZTS, NKTR)

By Nick Russo

Below are the three companies in the Pharmaceuticals industry with the highest Price to Last Quarter Annualized (LQA) Sales ratios. Price/LQA Sales is a valuable metric used to compare comparable companies using the most recent sales data on an annualized basis. Generally, the lower the ratio, the more undervalued the company.

Otonomy Inc ranks highest with a price to last quarter annualized sales ratio of 11.01. Lipocine Inc is next with a price to last quarter annualized sales ratio of 5.86. Collegium Pharma ranks third highest with a price to last quarter annualized sales ratio of 4.72.

Zoetis Inc follows with a price to last quarter annualized sales ratio of 2.41, and Nektar Therapeut rounds out the top five with a price to last quarter annualized sales ratio of 2.35.

SmarTrend recommended that its subscribers protect gains by selling shares of Otonomy Inc on March 11th, 2020 by issuing a Downtrend alert when the shares were trading at $2.68. Since that call, shares of Otonomy Inc have fallen 33.6%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: highest price to last quarter annualized sales ratio otonomy inc lipocine inc collegium pharma zoetis inc nektar therapeut

Ticker(s): OTIC LPCN COLL ZTS NKTR